Microvascular Therapeutics Appoints Charles Garrison, MD, to Scientific Advisory Board

emeuillet0

Sep 15

1 min read

Experienced pathologist, biotechnology entrepreneur, and life sciences investor will advise MVT on scientific and medical development

Recent Posts

Veteran family office executive and healthcare investor brings more than 30 years of investment, finance, and board experience.

University of Utah researchers use MVT-101 phase-shift nanobubbles with focused ultrasound and MRI to confirm treatment location